https://teapaw.org/t.co/DD95QRugJy https://teapaw.org/t.co/CvaQx0D8zg
Texas, America
Joined May 2015
- Tweets1.9K
- Following690
- Followers216
- Likes6.3K
Pinned Tweet
My debut solo album- an hour of heavy metal Christmas jams. Merry Christmas! youtube.com/playlist?list=PL…
6
2,089
Another Judge Andrews post, still not $LQDA. Probably hitting 'send' from a beach somewhere but at least it's something
3
15
1,436
$LQDA slow and steady on the way down, feels like another major holder wanted out (again). I assumed everyone got that out of their system last Monday, but alas
1
9
1,950
I wanted to keep my expectations low for today, but I'm so stoked to finally see this notification- feels surreal. I've been waiting for this day for years and can't believe I actually got in. Thank you @RobinhoodApp , love you guys. Regardless of what the stock does short term, @SpaceX is one of the most inspirational companies out there- there's no way I was going to sit on the sidelines for this one.
1
89
Excellent call all the way back to last Friday $LQDA
$LQDA tail wagging the dog, option exp today:
Roughly 16,000 OI calls in the money expire today, 1.6M shares. Many are deep in the money. So lots of activity can be expected. Shorting the stock with cover by exercise, or exercise and sell (part or all) today and Monday. Closing transactions. Roll out.
In stark contrast, there are almost no Puts expiring that are in the money.
Bottom line, there will be ample trading today and early next week as these option positions are resolved.
Dips will be buying ops for LONG term holds.
11
2,199
Benjamin Langner retweeted
Watching $LQDA hold onto it's gains after one positive catalyst after another in the best clinical and sales cycle of the company's existence
$LQDA update: spoke to her today for the first time since June. She tried Tyvaso but had to quit after a month- the cough was too much. Early last month, her pulmonologist started her on Yutrepia and she said it's noticeably better. Still has a cough with the first morning dose, but not nearly as severe as Tyvaso. As far as she can tell, Yutrepia is easier, more tolerable, and has more immediate results.
I asked her how she got started on Yutrepia- she said her pulmonologist recommended it, and explained the legal situation keeping it from the market until recently. She (the physician) clearly has a good understanding of the situation and was waiting for the green light before prescribing it, which is probably why I'm just now starting to see it more in my hospital in Dallas.
This is just one anecdote, but it's nice to see how it's slowly picking up in adoption in my clinic specifically and is hopefully a reflection of a broader trend- physicians in my area at least have a positive view of Yutrepia but have been cautiously navigating the legal stuff before fully embracing it
Just noticed this- for years, $LQDA has been in a legal battle against one of Forbes' Greatest American Innovators of All Time. Wow. No wonder the lawsuits keep coming, gotta keep that legacy alive. Very innovative
